News • Myalgic encephalomyelitis

Chronic fatigue syndrome: paving the way for better treatment

Associate Professor Rikke Katrine Jentoft Olsen from the Department of Clinical Medicine is taking part in an international research project aimed at generating new knowledge about myalgic encephalomyelitis (ME), also known as chronic fatigue syndrome. The project is receiving more than €7.5 million in EU funding.

Portrait photo of Rikke Katrine Jentoft Olsen
Rikke Katrine Jentoft Olsen

Image source: Aarhus University 

ME is a serious chronic illness that affects, among other things, the immune system, the nervous system and the body’s energy metabolism. At present, the condition is diagnosed on the basis of patients’ symptoms and by ruling out other illnesses. There are currently no biological markers that doctors can use to make the diagnosis. 

In the DISCOVER-ME research project, Rikke Katrine Jentoft Olsen and her research colleagues at the Molecular Medicine Research Unit (MMF), together with international partners, will search for biological characteristics of the illness. They will also investigate whether patients can be divided into different subgroups. “Our goal is for patients to receive an earlier diagnosis in the future and treatment tailored to their individual disease mechanisms,” says Rikke Katrine Jentoft Olsen from the Department of Clinical Medicine and the Department of Molecular Medicine. 

The researchers will collect data from 2,000 patients and carry out molecular analyses of more than 700 patients from five European biobanks. The data will be used to map clinical and biological differences and to develop AI-supported disease models that can identify existing active compounds with potential as treatments.

The project is funded through the EU’s Horizon Europe programme. Aarhus University is a partner in the four-year project and will receive €400,000 to map immunometabolic changes, with a particular focus on the role of mitochondria. The project grew out of the international biomedical research network European ME Research Group (EMERG), which, through more than ten years of collaboration, has built a research infrastructure for ME across Europe. 


Source: Aarhus University 

14.08.2026

Related articles

Photo

News • Focus on AMPA receptor density

Molecular basis of Long Covid's “brain fog” uncovered

New insights on the mechanisms that cause “brain fog” in Long Covid patients: Researchers use a specialized brain imaging technique to identify a potential biomarker and therapeutic target.

Photo

News • Auto-immune condition

Lupus: study explores causes and impact of diagnostic delays

Patients with systemic lupus erythematosus (SLE or ‘lupus’) may wait for up to 40 years to receive the correct diagnosis. New research highlights the causes and devastating impact of these delays.

Photo

News • Research on autoantibody patterns

The unique and complex origins of rheumatoid arthritis

New research challenges assumptions about the origin of rheumatoid arthritis, which are probably too simple. The findings may point towards improved diagnostics of this painful autoimmune disease.

Subscribe to Newsletter